Approximately 10–15% of couples worldwide have infertility and this is a serious health problem last 15-20 years. Progress in laboratory medicine expanded diagnostic capabilities over traditional hormonal, semen analysis and molecular genetics, immunoassays and artificial intelligence-based approaches. A comprehensive evaluation of current evidence is required to assess the clinical aviability of all diagnostic markers technologies